These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23927210)

  • 1. High intensity focused ultrasound ablation and antitumor immune response.
    Wu F
    J Acoust Soc Am; 2013 Aug; 134(2):1695-701. PubMed ID: 23927210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-Based Tumor Ablation: Role of the Immune Response.
    Wu F
    Adv Exp Med Biol; 2016; 880():131-53. PubMed ID: 26486336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model.
    Hu Z; Yang XY; Liu Y; Sankin GN; Pua EC; Morse MA; Lyerly HK; Clay TM; Zhong P
    J Transl Med; 2007 Jul; 5():34. PubMed ID: 17625013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host antitumour immune responses to HIFU ablation.
    Wu F; Zhou L; Chen WR
    Int J Hyperthermia; 2007 Mar; 23(2):165-71. PubMed ID: 17578340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-intensity focused ultrasound tumor ablation activates autologous tumor-specific cytotoxic T lymphocytes.
    Xia JZ; Xie FL; Ran LF; Xie XP; Fan YM; Wu F
    Ultrasound Med Biol; 2012 Aug; 38(8):1363-71. PubMed ID: 22633269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.
    Xu ZL; Zhu XQ; Lu P; Zhou Q; Zhang J; Wu F
    Ultrasound Med Biol; 2009 Jan; 35(1):50-7. PubMed ID: 18950932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
    Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
    Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies.
    van den Bijgaart RJ; Eikelenboom DC; Hoogenboom M; Fütterer JJ; den Brok MH; Adema GJ
    Cancer Immunol Immunother; 2017 Feb; 66(2):247-258. PubMed ID: 27585790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltration by macrophages and lymphocytes in transplantable mouse sarcoma after irradiation with high-intensity focused ultrasound.
    Chida S; Okada K; Suzuki N; Komori C; Shimada Y
    Anticancer Res; 2009 Oct; 29(10):3877-82. PubMed ID: 19846922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy.
    Hussain M; Javeed A; Ashraf M; Al-Zaubai N; Stewart A; Mukhtar MM
    Pharmacol Res; 2012 Jul; 66(1):7-18. PubMed ID: 22449788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.
    Wu F; Wang ZB; Lu P; Xu ZL; Chen WZ; Zhu H; Jin CB
    Ultrasound Med Biol; 2004 Sep; 30(9):1217-22. PubMed ID: 15550325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Intensity Focused Ultrasound- and Radiation Therapy-Induced Immuno-Modulation: Comparison and Potential Opportunities.
    Cirincione R; Di Maggio FM; Forte GI; Minafra L; Bravatà V; Castiglia L; Cavalieri V; Borasi G; Russo G; Lio D; Messa C; Gilardi MC; Cammarata FP
    Ultrasound Med Biol; 2017 Feb; 43(2):398-411. PubMed ID: 27780661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model.
    Wijlemans JW; Deckers R; van den Bosch MA; Seinstra BA; van Stralen M; van Diest PJ; Moonen CT; Bartels LW
    Invest Radiol; 2013 Jun; 48(6):381-6. PubMed ID: 23399810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Mechanical High-Intensity Focused Ultrasound Ablation with Chemotherapy for Augmentation of Anticancer Immune Responses.
    Li C; Lu Y; Cheng L; Zhang X; Yue J; Liu J
    Mol Pharm; 2021 May; 18(5):2091-2103. PubMed ID: 33886331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of blood supply on high intensity focused ultrasound a preliminary study on rabbit hepatic VX2 tumors of different ages.
    Zhou P; Zhou P; He W; Wang LH; Li XH; Tian SM; Qian Y; Chen LR
    Acad Radiol; 2012 Jan; 19(1):40-7. PubMed ID: 22054807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-intensity focused ultrasound ablation of uterine localized adenomyosis.
    Dong X; Yang Z
    Curr Opin Obstet Gynecol; 2010 Aug; 22(4):326-30. PubMed ID: 20610999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview.
    Wu F; Wang ZB; Chen WZ; Wang W; Gui Y; Zhang M; Zheng G; Zhou Y; Xu G; Li M; Zhang C; Ye H; Feng R
    Ultrason Sonochem; 2004 May; 11(3-4):149-54. PubMed ID: 15081972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
    Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical high-intensity focused ultrasound creates unique tumor debris enhancing dendritic cell-induced T cell activation.
    van den Bijgaart RJE; Mekers VE; Schuurmans F; Raaijmakers TK; Wassink M; Veltien A; Dumont E; Heerschap A; Fütterer JJ; Adema GJ
    Front Immunol; 2022; 13():1038347. PubMed ID: 36569907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.